Ocular lesions in HTLV-1 infected patients from Salvador, State of Bahia: The city with the highest prevalence of this infection in Brazil

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 42, Issue 6, 2009, Pages 633-637

  Rathsam Pinheiro, Regina Helena ^a,b   Boa Sorte, Ney ^b   Castro Lima Vargens, Cristina ^a   Pinheiro, Carlos Aldir ^a,b   Castro Lima, Humberto ^a,b   Galvão Castro, Bernardo ^b,c  

^a Instituto Brasileiro de Oftalmologia para Prevenção da Cegueira   (Brazil)

^b ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Corneal opacities; HTLV 1; Keratoconjunctivitis sicca; Ocular lesions; Uveitis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BIOMICROSCOPY; BRAZIL; CHILD; CORNEA OPACITY; EYE EXAMINATION; EYE MOVEMENT; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1 ASSOCIATED MYELOPATHY; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INTRAOCULAR PRESSURE; KERATOCONJUNCTIVITIS SICCA; LACRIMATION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; UVEITIS; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CHILD; CORNEAL OPACITY; CROSS-SECTIONAL STUDIES; FEMALE; HTLV-I INFECTIONS; HUMANS; KERATOCONJUNCTIVITIS SICCA; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; PREVALENCE; UVEITIS; YOUNG ADULT;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 77949984358     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822009000600004     Document Type: Article

References (36)

1. Barbosa HS, Bittencourt AL, Barreto de Araújo I, Pereira Filho CS, Furlan R, Pedrosa C, Lessa G, Harrington W Jr, Galvão Castro B.Adult T-cell leukemia/lymphoma in northeastern Brazil:a clinical, histopathologic, and molecular study Journal of Acquired Immune Deficiency Syndromes. 21:65-71, 1999.
2. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group Recommendation for the evaluation of intraocular inflammatory disease. American Journal of Ophthalmology 3:305-308, 2001.
3. Buggage RR, Levy-Clarke GA, Smith JA. New corneal findings in human T-cell lymphotropic virus type 1 infection. American Journal of Ophthalmology 131:309-313, 2001.
4. Dourado I, Alcantara LC, Barreto ML, Teixeira MG, Galvão-Castro B. HTLV-I in the general population of Salvador, Brazil:a city with African ethnic and sociodemographic characteristics. Journal of Acquired Immune Deficiency Syndromes 34:527-531, 2003.
5. Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I) The Journal of Emergency Medicine 18:109-119, 2000.
6. Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, Kawakami A, Terada K, Shimada H, Kawabe Y, FukudaT, Sawada T, Nagataki S. Primary Sjogren's syndrome with antibodies to HTLV-I: clinical and laboratory features. Annals of the Rheumatic Diseases 51:769-576, 1992.
7. Farris RL, Gilbard JP, Stuchell RN, Mandel ID. Diagnostic Tests in Keratoconjuntivitis Sicca. The CLAO Journal 9:23-28, 1983.
8. Ferraz-Chaoui AK, Atta AM, Galvão-Castro B, Santiago MB. Study ofautoantibodies in patients with keratoconjuntivitis sicca infected by the human T cell lymphotropic virus type 1. Rheumatology International 2009 Jul 29. [Epub ahead of print].
9. Galvão-Castro B, Loures L, Rodriques LG, Sereno A, Ferreira Júnior OC, Franco LG, Muller M, Sampaio DA, Santana A, Passos LM, Proietti F. Distribution of humanT-lymphotropic virus type I among blood donors:a nationwide Brazilian study. Transfusion 37:242-243, 1997.
10. Gessain A, Barin E, Vernant JC, Gout O, Maurs L, Calender A. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 2:407-410, 1985.
11. Gomes I, Melo A, Proietti FA, Moreno-Carvalho O, Loures LA, Dazza MC, Said G, Larouzé B, Galvão-Castro B.Human T lymphotropic virus type I (HTLV-I) infection in neurological patients in Salvador, Bahia, Brazil. Journal of the Neurological Sciences 165:84-89, 1999.
12. Ikeda E, Ono A, Hikita N, Arima K, Mochizuki M, Yamaguchi K, Tajima K, Kiyokawa H. Estimated prevalence rate of HTLV-I uveitis in Chikugo. Nippon Ganka Gakkai Zasshi 102:327-332, 1998.
13. Kashima S, Alcantara LC, Takayanagui OM, Cunha MA, Castro BG, Pombo-de-Oliveira MS, Zago MA, Covas DT. Distribution of human T cell lymphotropic virus type 1 (HTLV-1) subtypes in Brazil:genetic characterization of LTR and tax region. AIDS Research and Human Retroviruses 22:953-959, 2006.
14. a edition. Philadelphia: Butterworth Heinemann 5:270-308, 2003.
15. La Grenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children:a marker for HTLV-I infection. Lancet 336:1345-1347, 1990.
16. Levine PH, Blattner WA. The epidemiology of diseases associated with HTLV-I and HTLV-II. Infectious Disease Clinics of North America. 1:501-510, 1987.
17. Levy-Clarke G, Buggage R, Shen DF, Vaughn LO, Chan CC, Davis JL. Human T-cell lymphotropic virus type-I associated T-cell leukemia-lymphoma masquerading as necrotizing retinal vasculitis. Ophthalmology 109:1717-1722, 2002.
18. Merle H, Cabre P, Olindo S, Merle S, Smadja D. Ocular lesions in 200 patients infected by the Human T-cell lymphotropic virus type 1 in Martinique (French West Indies). American Journal of Ophthalmology 134:190-195, 2002.
19. Merle H, Donnio A, Gonin C, Jean-Charles A, Panelatti G, Plumelle Y. Retinal vasculitis caused by adult T-cell leukemia/lymphoma. Japanese Journal of Ophthalmology 49:41-45, 2005.
20. Merle H, Smadja D, Le Hoang P, Bera O, Cabre P, Landau M, Vernant JC. Ocular manifestations in patients with HTLV-I associated infection:a clinical study of 93 cases. Japanese Journal of Ophthalmology 40:260-270, 1996.
21. Mochizuki M. Human T-lymphotropic virus type 1 and its ocular manifestations International Ophthalmology Clinics 107-120, 1995.
22. Mochizuki M, Ono A, Ikeda E, Hikita N, Watanabe T, Yamaguchi K, Sagawa K, Ito K. HTLV-I uveitis.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 13 (Suppl 1):S50-56, 1996.
23. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Shirao M, Yoshimura K,Nakashima S, Mori S, Araki S, Miyata N. HTLV-1 uveitis:a distinct clinical entity caused by HTLV-1. Japanese Journal of Cancer Research 83:236-239, 1992.
24. Mueller N. The epidemiology of HTLV-I infection. Cancer Causes Control 2:37-52, 1991
25. Nakao K, Ohba N, Matsumoto M. Noninfectious anterior uveitis in patients infected with human T Lymphotropic virus type I. Japanese Journal of Ophthalmology 33:472-478, 1989.
26. Nunes C, Mascarenhas-Batista AV, Maltês D, Brandão JCD, Ferreira TS, Seabra AML. Características Clínicas - Epidemiológicas de 385 pacientes portadores de HTLV na Bahia. In:IX Simpósio Internacional sobre HTLV no Brasil; 2006 Set 19-22, Belo Horizonte, Brasil; Revista da Sociedade Brasileira de Medicina Tropical. 39 :71,2006.
27. Oliveira M de F, Brites C, Ferraz N, Magalhães P, Almeida F, Bittencourt AL. Infective dermatitis associated with the human T cell lymphotropic virus type I in Salvador, Bahia, Brazil. Clinical Infectious Diseases 40:90-96, 2005.
28. st edition. Raven Press: New York p. 191-197, 1990
29. Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A. HTLV-1 associated myelopathy, a new clinical entity. Lancet 1:1031- 1032, 1986.
30. Pinheiro SR, Martins-Filho OA, Ribas JG, Catalan-Soares BC, Proietti FA, Namen-Lopes S, Brito-Melo GE, Carneiro-Proietti AB, InterdisciplinaryHTLV-I/II Research Group (GIPH). Immunologic markers, uveitis, and keratoconjuntivitis sicca associated with Human T-Cell lymphotropic virus type 1. American Journal of Ophthalmology 20:1-5, 2006.
31. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America 77:7415-7419, 1980.
32. Proietti FA, Carneiro-Proietti ACF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 24:6058-6068, 2005.
33. Secretaria de Vigilância em Saúde. Guia do manejo clínico do HTLV (Série A. Normas e Manuais Técnicos no. 3) Programa Nacional de DST e Aids. - Brasília: Ministério da Saúde, 2003.
34. Soares R, Moraes Jr H. Manifestações oculares observadas em indivíduos infectados por HTLV-I no Rio de Janeiro. Arquivos Brasileiros de Oftalmologia. 63:293-298, 2000.
35. Yamamoto JH, Segurado AA, Hirata CE, Sampaio MW, Souza EC, Nukui Y, Cliquet M, Saéz-Alquézar A, Olivalves E, Mochizuki M. Human T-lymphotropic virus type 1 infection and ocular manifestations in São Paulo, Brazil. Archives of Ophthalmology 117:513-517, 1999.
36. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cells lines of human adult T-cell leukemia and its implications in the disease. Proceedings of the National Academy of Sciences of the United States of America 79:2031-2035, 1982.